Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2022 / Jan / Sequencing Access for All
Genetics and epigenetics Technology and innovation Molecular Pathology

Sequencing Access for All

An affordable genome sequencing pipeline for low- and middle-income countries

By Liv Gaskill 01/24/2022 Quick Read (pre 2022) 1 min read

Share

Though the first bacterial genome was sequenced over two decades ago, the technology has largely been limited to high-income countries – creating a disparity between the need for bacterial sequencing and its accessibility. Now, a worldwide consortium of scientists has developed an inexpensive pipeline for collecting and sequencing bacterial pathogens – for less than US$10 per genome (1).

The consortium used Salmonella enterica to test their method. “The number of publicly available sequenced Salmonella genomes reached 350,000 in 2021,” said study author Neil Hall (2). “However, limited genome-based surveillance of Salmonella infections has been done in [low- and middle-income] countries and the existing dataset did not accurately represent the Salmonella pathogens that are currently causing disease across the world.”

The LITE (Low Input, Transposase Enabled) pipeline has a low DNA requirement – reporting that, for Salmonella, 1 ng is equal to over 150,000 copies of the genome. With a diverse collection of 10,419 bacterial isolates, the researchers successfully generated 6,117 high-quality Salmonella genomes that have already been used in published studies. “Our pipeline represents a cost-effective and robust tool for generating bacterial genomic data […] to allow investigation of the epidemiology, drug resistance, and virulence factors of isolates,” said Darren Heavens, who developed the whole-genome sequencing pipeline.

Overall, the work represents the value of global collaboration to tackle future epidemics and pandemics. Going forward, the authors suggest that “early investment in the development of a shared, protected, and version-controlled database for the storage of epidemiological information” is needed to implement approaches like theirs worldwide.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

    1. BM Perez-Sepulveda et al., Genome Biol, 22, 349 (2021). PMID: 34930397.
    2. University of Liverpool (2021). Available at: https://bit.ly/3GwmPo1.

About the Author(s)

Liv Gaskill

During my undergraduate degree in psychology and Master’s in neuroimaging for clinical and cognitive neuroscience, I realized the tasks my classmates found tedious – writing essays, editing, proofreading – were the ones that gave me the greatest satisfaction. I quickly gathered that rambling on about science in the bar wasn’t exactly riveting for my non-scientist friends, so my thoughts turned to a career in science writing. At Texere, I get to craft science into stories, interact with international experts, and engage with readers who love science just as much as I do.

More Articles by Liv Gaskill

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Breathing New Life into Diagnostics
Genetics and epigenetics
Breathing New Life into Diagnostics

January 22, 2024

6 min read

Jonathan Edgeworth on how metagenomics could transform testing for respiratory infections

Molecular Spectacular
Genetics and epigenetics
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

Redefining Diagnostic Reference Standards
Genetics and epigenetics
Redefining Diagnostic Reference Standards

January 3, 2022

1 min read

Find out what Horizon Discovery’s diagnostic reference standards can do for your workflow

Defining the Next Generation of NGS
Genetics and epigenetics
Defining the Next Generation of NGS

December 31, 2021

1 min read

Overcoming challenges of the typical NGS workflow with the Ion Torrent™ Genexus™ System

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.